BR112012012384A2 - processo para preparar um polímero do sal de colina de [4,6-bi(dimetilamino--2-(4-{[4-(trifluorometil)-benzoil]amino}benzil)pirimidin-5-il} - Google Patents

processo para preparar um polímero do sal de colina de [4,6-bi(dimetilamino--2-(4-{[4-(trifluorometil)-benzoil]amino}benzil)pirimidin-5-il}

Info

Publication number
BR112012012384A2
BR112012012384A2 BR112012012384A BR112012012384A BR112012012384A2 BR 112012012384 A2 BR112012012384 A2 BR 112012012384A2 BR 112012012384 A BR112012012384 A BR 112012012384A BR 112012012384 A BR112012012384 A BR 112012012384A BR 112012012384 A2 BR112012012384 A2 BR 112012012384A2
Authority
BR
Brazil
Prior art keywords
pyrimidin
dimethylamino
benzoyl
trifluoromethyl
benzyl
Prior art date
Application number
BR112012012384A
Other languages
English (en)
Inventor
Bing-Shiou Yang
Dhileep Krishnamurthy
Juan Manuel Rodriguez Dehli
Michael Schul
Xiao-Jun Wang
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43447007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012012384(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR112012012384A2 publication Critical patent/BR112012012384A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

processo para preparar um polimorfo do sal de colina de [4,6-bi(dimetilamino)-2-(4-{[4-(trifluorometil)-benzoil]amino}benzil)pirimidin-5-il]. a presente refere-se a um processo para preparar um sal de colina de ácido [4,6-bis(dimetilamino)-2-(4-{[4-(trifluorometil)benzoil}benzil)pirimidin-5-il] acético. o processo de invenção é útil para preparar o sal nas formas mais puras do sal. também da invenção é útil para forma mais pura do sal de colina de ácido [4,6-bis(dimetilamino)-2-(4-{[4-(trifluorometil)benzoil]amino}benzil)pirimidin-5-il]acético.
BR112012012384A 2009-11-24 2010-11-19 processo para preparar um polímero do sal de colina de [4,6-bi(dimetilamino--2-(4-{[4-(trifluorometil)-benzoil]amino}benzil)pirimidin-5-il} BR112012012384A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26387109P 2009-11-24 2009-11-24
PCT/US2010/057312 WO2011066176A1 (en) 2009-11-24 2010-11-19 Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative

Publications (1)

Publication Number Publication Date
BR112012012384A2 true BR112012012384A2 (pt) 2016-03-22

Family

ID=43447007

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012012384A BR112012012384A2 (pt) 2009-11-24 2010-11-19 processo para preparar um polímero do sal de colina de [4,6-bi(dimetilamino--2-(4-{[4-(trifluorometil)-benzoil]amino}benzil)pirimidin-5-il}

Country Status (15)

Country Link
US (1) US20110294828A1 (pt)
EP (1) EP2504319A1 (pt)
JP (1) JP2013512242A (pt)
KR (1) KR20120101399A (pt)
CN (1) CN102666499A (pt)
AR (1) AR079128A1 (pt)
AU (1) AU2010324980A1 (pt)
BR (1) BR112012012384A2 (pt)
CA (1) CA2781610A1 (pt)
CL (1) CL2012001170A1 (pt)
EA (1) EA201200765A1 (pt)
IL (1) IL218990A0 (pt)
MX (1) MX2012006003A (pt)
TW (1) TW201200501A (pt)
WO (1) WO2011066176A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
GR861995B (en) 1985-07-30 1986-11-04 Glaxo Group Ltd Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
EP1471057B1 (en) * 2003-04-25 2006-01-18 Actimis Pharmaceuticals, Inc. Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2
CA2659189A1 (en) 2006-08-03 2008-02-07 Bromine Compounds Ltd. Method, device and system for water treatment
RU2468012C2 (ru) 2007-06-21 2012-11-27 Актимис Фармасьютикалз, Инк. Частицы антагониста crth2
CN101772489B (zh) 2007-06-21 2013-02-20 艾克提麦斯医药品有限公司 一种crth2拮抗剂的胺盐

Also Published As

Publication number Publication date
WO2011066176A1 (en) 2011-06-03
EA201200765A1 (ru) 2013-02-28
MX2012006003A (es) 2012-06-19
AU2010324980A1 (en) 2012-05-03
KR20120101399A (ko) 2012-09-13
CN102666499A (zh) 2012-09-12
JP2013512242A (ja) 2013-04-11
US20110294828A1 (en) 2011-12-01
IL218990A0 (en) 2012-06-28
CA2781610A1 (en) 2011-06-03
EP2504319A1 (en) 2012-10-03
TW201200501A (en) 2012-01-01
CL2012001170A1 (es) 2012-10-12
AR079128A1 (es) 2011-12-28

Similar Documents

Publication Publication Date Title
BRPI1015062A2 (pt) "processo para preparar ácido fórmico"
DOP2016000285A (es) Procedimiento para la preparación de 4-­{4-­[({[4-­cloro-­3-­(trifluorometil)fenil]amino}carbonil)amino]-­3-­fluorofenoxi}-­n-­metilpiridina-­2-­carboxamida, sus sales y su monohidrato
BR112015005404A2 (pt) Formas polimórficas de enzalutamida e sua preparação
BRPI0905147A8 (pt) processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável
BR112012012584A2 (pt) "processo para preparar sais de 4,5-diidroisoxazol-3-tiocarboxamidina 5,5-dissubstituídos de fórmula (i)"
BRPI0822106A2 (pt) "processo para preparação de ácido metacrílico de alta pureza."
MY165908A (en) Heterocyclic compound and use thereof
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
BR112013002925A2 (pt) processo para a síntese de ácido 2,5-furandicarboxílico
BRPI0908891A2 (pt) Processo para síntese regiosseletiva de derivados de ácido 1-alquil-3-haloalquil-pirazol-4-carboxílico
BRPI0819182A2 (pt) Polímero, proceso para preparar o mesmo, derivados, e, processo para preparar os mesmos
BRPI0922984A2 (pt) processo para preparar trietanolamina pura
BR112013031120A2 (pt) processo para a preparação de ácido fórmico
BR112012000209A2 (pt) processo para a produção de heterodímeros de ácido glutâmico
BR112014004210A2 (pt) processo para a preparação de derivados de diamida do ácido antranílico substituídos com tetrazole por reação de benzoxazinonas com aminas
BR112012002500A2 (pt) Processo para o preparo de derivados de ácido 1- (2-halobifenil-4-yl) - ciclopropanocarboxílico
BRPI0907872A2 (pt) Processo para produção de ácido dicarboxílico
BR112013018942A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluro-6(substituído) picolinatos.
BRPI0909771A2 (pt) processo para preparar ácido cianídrico
BRPI1013871A2 (pt) Processo para a preparação de derivados de ácido propiônico.
BRPI0820289A2 (pt) Processo para preparar ácido cianídrico, e, uso de um microevaporador.
BRPI0909813A2 (pt) processo para a preparação de derivados de ácido ciclohexanocarboxílico
BR112013019045A2 (pt) processo para fabricar um artigo tipo papel, e, uso de ácido metanossulfônico
BR112013031201A2 (pt) derivados de sulfonamida heterocíclicos, composição farmacêutica os compreendendo, uso, processo para a fabricação de (r)-n-(4,5-difluoro-6-((2-fluoro-4-iodofenil)amino)benzofuran-7-il)-1-(2,3-di-idroxipropil)ciclopropano-5 1-sulfonamida e kit
BR112014003730A2 (pt) processo para a preparação de derivados de tietano

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.